Biagio Ricciuti

Chemo-immunotherapie ± VEGF-remming na falen van EGFR-TKI bij EGFR-gemuteerd NSCLC: meta-analyse op IPD-niveau

TTF-1-expressie bij longadenocarcinoom: klinisch-pathologische, genomische en immunofenotypische correlaties

Impact van KRAS-mutaties en co-alteraties op uitkomsten bij stadium III niet-plaveiselcellig NSCLC na CRT

Neoadjuvant vs perioperative chemo-immunotherapy according to pathological response in resectable non-small cell lung...

Long-term totale overleving with dual CTLA-4 and PD-L1 or PD-1 blockade and biomarker-based subgroup analyses in pati...

Genomisch landschap van NSCLC bij systemische sclerose: frequente TP53-mutaties

MAPK Pathway-Activating Alteration and Immunotherapy Efficacy in Squamous Cell Lung Carcinoma: Results from the Geran...